Salta al contenuto principale
TECA™ Pharma

TECA™ Pharma

An Active Pharmaceutical Ingredient for wound healing and venous insufficiency

First Centella asiatica extract to be used for medicinal applications, TECA™ Pharma comes with a 50-year track record of use in drug products for wound healing and venous insufficiency.


INCI: Asiaticoside - Madecassic Acid - Asiatic Acid
Composition: 40% Asiaticoside, 60% Genins
Form: powder
Use: 0.1 to 1%

Application: topical, oral
End product status: marketing authorization, over-the-counter, medical device


TECA™ Pharma is a titrated extract of Centella asiatica, with proven biological activity:

  • Promotion of collagen synthesis through the stimulation of dermal fibroblasts
  • Angiogenesis modulation
  • Stimulation of extracellular matrix remodeling

These regenerative properties bring benefits to the wound healing process, with a 40% reduction of time to closure through topical application of TECA™ Pharma.

Through clinical trials, oral administration of TECA™ Pharma was shown to significantly improve life-conditions of patients with venous insufficiency, reducing lower limbs heaviness, pain and oedema, and promoting oxygenation of surrounding tissues.

Safe & Reliable active

Good Manufacturing Practice (GMP)
“Active Substance Master File” (ASMF) available on request
Full toxicological/tolerance data available on request

Would you like a sample of this ingredient ?

Previous product


Powder solubilizing agent for solid oral forms

Next product


AMONYL™ are foaming amphoteric surfactants in liquid form